News
1d
Medical Device Network on MSNBoston Scientific reports outcomes from Farapulse and Farapoint trialSubjects in the study were monitored using the LUX-Dx insertable cardiac monitor system to detect arrhythmia recurrence.
Patients with a high probability of HFpEF may experience greater benefits from atrial fibrillation ablation than those with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results